Source: BioPortfolio

Exscientia: Ex Scientia Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

SummaryEx Scientia Ltd Ex Scientia is a biotechnology company that develops compounds with tailored polypharmacology. The company develops a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. It also de...

Read full article »
Exscientia's Competitors | Exscientia's News | Exscientia's Financials
Stay up-to-date with the latest news on Exscientia
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Andrew Hopkins's photo - Founder & CEO of Exscientia

Founder & CEO

Andrew Hopkins

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on Exscientia